Biofeedback of baroreflex sensitivity in patients with mild essential hypertension.
An attempt was made to reduce blood pressure by increasing the baroreflex sensitivity (BRS) via biofeedback. Six patients with mild essential hypertension and 5 normotensive participants were studied during 8 biofeedback sessions. Each session consisted of 5 trials, 5 min each. The first and the last trials served as baselines of heart rate, blood pressure, respiration, and BRS. During the 3 middle trials the BRS was calculated online using the sequencing technique. The resulting value was used as a visual analogue feedback signal. Participants were asked to increase BRS. The mean BRS was 8.3 [ms/mmHg] for the hypertensive patients and 12.2 [ms/mmHg] for the normotensive participants. During biofeedback trials as well as across sessions neither the hypertensive nor the normotensive group showed a statistically significant increase of BRS, only heart rate variability increased significantly. Contrary to expectation blood pressure increased in both groups. One hypertensive subject made significant progress during the training by performing valsalva maneuvers. The data show that BRS is reduced in hypertensive subjects. The increase of the heart rate variability could be a sign of the activation of the baroreflex although the BRS itself did not increase. Despite the successful technical and organizational implementation of this biofeedback approach, it was not effective to systematically reduce blood pressure. A further development in the direction of guiding the patient to use the valsalva breathing pattern and/or a prolonged duration of the biofeedback training might be promising.
Overhaus
Sabine
S
Department of Clinical and Applied Psychology, University of Bonn, Roemerstrasse, Germany.
Rüddel
Heinz
H
Curio
Immo
I
Mussgay
Lutz
L
Scholz
O Berndt
OB
D000328:Adult; D017704:Baroreflex / Q000502:physiology*; D001676:Biofeedback, Psychology; D005260:Female; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000523:psychology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome